MedTrace Logo

Adherence and Persistence to Inclisiran Among Early Users in Germany

NCT05870657 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1109

Last updated 2023-05-23

No results posted yet for this study

Summary

The present study was a descriptive, non-interventional, retrospective cohort study aimed at evaluating early data on adherence, persistence, and treatment patterns among patients receiving inclisiran and other lipid-lowering therapies (LLT) in a real-world setting in Germany. Analysis was carried out using the IQVIA™ LRx database.

Conditions

  • High Levels of Low-density Lipoprotein Cholesterol

Sponsors & Collaborators

Principal Investigators

  • Novartis Pharmaceuticals · Novartis Pharmaceuticals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-16
Primary Completion
2022-05-12
Completion
2022-05-12

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05870657 on ClinicalTrials.gov